(a)
(b)
(c)
(d)
(e)
(f)
Figure 5: Molecular docking between galangin/pinocembrin and human insulin receptor. Note: (a) is the chemical structure of galangin. (b) is the chemical structure of pinocembrin. (c) shows the results of galangin docking with human insulin receptor. (d) shows the results of pinocembrin docking with human insulin receptor. (e) is a visual analysis of galangin docking with the human insulin receptor. (f) is a visual analysis of pinocembrin docking with the human insulin receptor.